QIMR Berghofer-led research in collaboration with Australian oncology company Kazia Therapeutics has found that combining the drug candidate paxalisib with immunotherapy triggered a molecular ...

Desperate times call for creative solutions, and Chinese cat owners are proving this by repurposing COVID-19 medication to ...

B-cells are a vital part of the immune system, and although this drug combination will destroy the cells while the patient is on treatment, the body should begin producing them again once treatment is ...